Neurofit, an AI solutions company specializing in brain diseases, hit the upper price limit during trading following news that Samsung Active Asset Management had acquired a stake in the company.


As of 10:20 a.m. on January 30, Neurofit was trading at 28,250 won on the Korea Exchange, up 6,500 won (29.89%) from the previous session. After reaching the upper price limit early in the session, trading has continued at the same price.


The previous day, Samsung Active Asset Management announced that it had newly acquired 582,764 shares of Neurofit. The stake amounts to 5.01%, and the stated purpose of the holding is "simple investment."


Neurofit is a company specializing in diagnosis and treatment across the entire cycle of brain diseases. The company was listed on the KOSDAQ market in July of last year, and in October, it established a local subsidiary in the state of Delaware in the United States.



[Market Focus] Neurofit Hits Upper Price Limit on News of Samsung Active Asset Management Stake Acquisition View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing